1613401-87-8

Basic information

• Product Name: tert-butyl 7-(4-(2-methyl-4-(trifluoromethoxy)phenyl)-2-oxopyridin-1(2H)-yl)-3,4-dihydrobenzofuro[3,2-c]pyridine-2(1H)-carboxylate
• Synonyms: tert-butyl 7-(4-(2-methyl-4-(trifluoromethoxy)phenyl)-2-oxopyridin-1(2H)-yl)-3,4-dihydrobenzofuro[3,2-c]pyridine-2(1H)-carboxylate
• CAS NO: 1613401-87-8
• Molecular Weight: 540.539
• Mol File: 1613401-87-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl 7-(4-(2-methyl-4-(trifluoromethoxy)phenyl)-2-oxopyridin-1(2H)-yl)-3,4-dihydrobenzofuro[3,2-c]pyridine-2(1H)-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 7-(4-(2-methyl-4-(trifluoromethoxy)phenyl)-2-oxopyridin-1(2H)-yl)-3,4-dihydrobenzofuro[3,2-c]pyridine-2(1H)-carboxylate(1613401-87-8)
• EPA Substance Registry System: tert-butyl 7-(4-(2-methyl-4-(trifluoromethoxy)phenyl)-2-oxopyridin-1(2H)-yl)-3,4-dihydrobenzofuro[3,2-c]pyridine-2(1H)-carboxylate(1613401-87-8)

Safety Data

• Hazardous Substances Data: 1613401-87-8(Hazardous Substances Data)

Upstream product

• 1613401-85-6 2-methoxy-4-(2-methyl-4-(trifluoromethoxy)phenyl)pyridine 
• 850033-39-5 4,4,5,5-tetramethyl-2-[2-methyl-4-(trifluoromethoxy)phenyl]-1,3,2-dioxaborolane 
• 100367-39-3 4-bromo-2-methoxypyridine 
• 1387003-37-3 tert-butyl 7-bromo-3,4-dihydrobenzofuro[3,2-c]pyridine-2(1H)-carboxylate 
• 1613401-86-7 4-(2-methyl-4-(trifluoromethoxy)phenyl)pyridin-2(1H)-one 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 

Downstream Products

• 1613400-53-5 4-(2-methyl-4-(trifluoromethoxy)phenyl)-1-(1,2,3,4-tetrahydrobenzofuro[3,2-c]pyridin-7-yl)pyridin-2(1H)-one 

Relevant articles and documents

PYRIDO-/AZEPINO-BENZOFURAN AND PYRIDO-/AZEPINO-BENZOTHIOPHENE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF

Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described.